Skip to main content

Advertisement

Log in

Underestimation rate of lobular intraepithelial neoplasia in vacuum-assisted breast biopsy

  • Breast
  • Published:
European Radiology Aims and scope Submit manuscript

An Erratum to this article was published on 28 May 2014

Abstract

Objectives

To evaluate the underestimation rate and clinical relevance of lobular neoplasia in vacuum-assisted breast biopsy (VABB).

Methods

A total of 161 cases of LN were retrieved from 6,435 VABB. The histological diagnosis was ALH (atypical lobular hyperplasia) in 80 patients, LCIS (lobular carcinoma in situ) in 69 patients and PLCIS (pleomorphic lobular carcinoma in situ) in 12 patients. Seventy-six patients were operated on within 2 years after VABB and 85 were clinically and radiologically monitored. The mean follow-up was 5.2 years, and the prevalence of malignancy was evaluated in the group of 85 patients.

Results

The clinico-pathological characteristics significantly favouring surgery were larger lesions, occurrence of a residual lesion following VABB and histological LCIS and PLCIS subtypes. The VABB underestimation rate as compared to surgery was 7.1 % for ALH, 12 % for LCIS and 50 % for PLCIS. Overall, 11 of the 148 patients included in this survival analysis developed an ipsilateral tumour.

Conclusion

Although obtained retrospectively in a relatively small series of patients, our data suggest that only patients with a diagnosis of PLCIS in VABB should be treated with surgery, whereas patients with ALH and LCIS could be monitored by clinical and radiological examinations.

Key Points

The treatment of ALH and LCIS in VABB is still debated

Some authors favour radical treatment and others a more conservative approach

Only patients with PLCIS in VABB should be treated by surgery

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2

Similar content being viewed by others

Abbreviations

ADH:

Atypical ductal hyperplasia

ALH:

Atypical lobular hyperplasia

BI-RADS:

Breast imaging reporting and data system

DCIS:

Ductal carcinoma in situ

DFS:

Disease-free survival

IDC:

Invasive ductal cancer

ILC:

Invasive lobular cancer

LCIS:

Lobular carcinoma in situ

LN:

Lobular neoplasia

MRI:

Magnetic resonance imaging

PLCIS:

Pleomorphic lobular carcinoma in situ

TDLU:

Terminal duct lobular unit

US:

Ultrasound

VABB:

Vacuum-assisted breast biopsy

References

  1. Foote FW, Stewart FW (1941) Lobular carcinoma in situ: a rare form of mammary cancer. Am J Pathol 17:491–496

    CAS  PubMed Central  PubMed  Google Scholar 

  2. Haagensen CD, Lane N, Lattes R et al (1978) Lobular neoplasia (so-called lobular carcinoma in situ) of the breast. Cancer 42:737–769

    Article  CAS  PubMed  Google Scholar 

  3. Hussain M, Cunnick GH (2011) Management of lobular carcinoma in-situ and atypical lobular hyperplasia of the breast. A review. EJSO 37:279–289

    Article  CAS  PubMed  Google Scholar 

  4. Brogi E, Murray MP, Corben AD (2010) Lobular carcinoma, not only a classic. Breast J 16:S10–S14

    Article  PubMed  Google Scholar 

  5. Simpson PT, Reis-Filho JS, Lambros MB et al (2008) Molecular profiling pleomorphic lobular carcinomas of the breast: evidence for a common molecular genetic pathway with classic lobular carcinomas. J Pathol 215:231–244

    Article  CAS  PubMed  Google Scholar 

  6. Carder PJ, Shaaban AM, Alizadeh Y et al (2010) Screen-detected pleomorphic lobular carcinoma in situ (PLCIS): risk of concurrent invasive malignancy following a core biopsy diagnosis. Histopathology 57:472–478

    Article  PubMed  Google Scholar 

  7. Chen YY, Hwang ES, Roy R et al (2009) Genetic and phenotypic characteristics of pleomorphic lobular carcinoma in situ of the breast. Am J Surg Pathol 33:1683–1694

    Article  PubMed Central  PubMed  Google Scholar 

  8. Masannat YA, Bains SK, Pinder SE et al (2013) Challenges in the management of pleomorphic lobular carcinoma in situ of the breast. Breast 22:194–196

    Article  PubMed  Google Scholar 

  9. Lakhani S (2012) WHO classification of tumours of the breast, 4th edn. International Agency for Research on Cancer, Lyon

    Google Scholar 

  10. Bratthauer GL, Tavassoli FA (2002) Lobular intraepithelial neoplasia: previously unexplored aspects assessed in 775 cases and their clinical implications. Virchows Arch 440:134–138

    Article  PubMed  Google Scholar 

  11. Chuba PJ, Hamre MR, Yap J et al (2005) Bilateral risk for subsequent breast cancer after lobular carcinoma-in-situ: analysis of surveillance, epidemiology, and end results data. J Clin Oncol 23:5534–5541

    Article  PubMed  Google Scholar 

  12. O’Malley FP (2010) Lobular neoplasia: morphology, biological potential and management in core biopsies. Mod Pathol 23:S14–S25

    Article  PubMed  Google Scholar 

  13. Provencher L, Jacob S, Côté G et al (2012) Low frequency of cancer occurrence in same breast quadrant diagnosed with lobular neoplasia at percutaneous needle biopsy. Radiology 263:43–52

    Article  PubMed  Google Scholar 

  14. Wheeler JE, Enterline HT, Roseman JM et al (1974) Lobular carcinoma in situ of the breast. Long-term followup. Cancer 34:554–563

    Article  CAS  PubMed  Google Scholar 

  15. Page DL, Kidd TE Jr, Dupont WD et al (1991) Lobular neoplasia of the breast: higher risk for subsequent invasive cancer predicted by more extensive disease. Hum Pathol 22:1232–1239

    Article  CAS  PubMed  Google Scholar 

  16. Shah-Khan MG, Geiger XJ, Reynolds C et al (2012) Long-term follow-up of lobular neoplasia (atypical lobular hyperplasia/lobular carcinoma in situ) diagnosed on core needle biopsy. Ann Surg Oncol 19:3131–3138

    Article  PubMed  Google Scholar 

  17. Dmytrasz K, Tartter PI, Mizrachy H et al (2003) The significance of atypical lobular hyperplasia at percutaneous breast biopsy. Breast J 9:10–12

    Article  PubMed  Google Scholar 

  18. Georgian-Smith D, Lawton TJ (2012) Variations in physician recommendations for surgery after diagnosis of a high-risk lesion on breast core needle biopsy. AJR 198:256–263

    Article  PubMed  Google Scholar 

  19. Cutuli B, de Lafontan B, Quetin P et al (2005) Breast-conserving surgery and radiotherapy: a possible treatment for lobular carcinoma in situ? Eur J Cancer 41:380–385

    Article  PubMed  Google Scholar 

  20. Niell B, Specht M, Gerade B et al (2012) Is excisional biopsy required after a breast core biopsy yields lobular neoplasia? AJR 199:929–935

    Article  PubMed  Google Scholar 

  21. Cohen MA (2004) Cancer upgrades at excisional biopsy after diagnosis of atypical lobular hyperplasia or lobular carcinoma in situ at core-needle biopsy: some reasons why. Radiology 231:617–621

    Article  PubMed  Google Scholar 

  22. Linda A, Zuiani C, Furlan A et al (2012) Nonsurgical management of high-risk lesions diagnosed at core needle biopsy: can malignancy be ruled out safely with breast MRI? AJR 198:272–280

    Article  PubMed  Google Scholar 

  23. Friedlander LC, Roth SO, Gavenonis SC (2011) Results of MR imaging screening for breast cancer in high-risk patients with lobular carcinoma in situ. Radiology 261:421–427

    Article  PubMed  Google Scholar 

  24. Sung JS, Malak SF, Bajaj P et al (2011) Screening breast MR imaging in women with a history of lobular carcinoma in situ. Radiology 261:414–420

    Article  PubMed  Google Scholar 

  25. Sohn VY, Arthurs ZM, Kim FS et al (2008) Lobular neoplasia: is surgical excision warranted? Am Surg 74:172–177

    PubMed  Google Scholar 

  26. Renshaw AA, Cartagena N, Derhagopian RP et al (2002) Lobular neoplasia in breast core needle biopsy specimens is not associated with an increased risk of ductal carcinoma in situ or invasive carcinoma. Am J Clin Pathol 117:797–799

    Article  PubMed  Google Scholar 

  27. Nagi CS, O'Donnell JE, Tismenetsky M et al (2008) Lobular neoplasia on core needle biopsy does not require excision. Cancer 112:2152–2158

    Article  PubMed  Google Scholar 

  28. Fischer B, Costantino JP, Wickerham DL et al (1998) Tamoxifen for prevention of breast cancer: report of the national surgical adjuvant breast & bowel project P-1 study. J Natl Cancer Inst 90:1371–1388

    Article  Google Scholar 

  29. European Commission (2005) European guidelines for quality assurance in mammography screening, 3rd edn. EC, Luxembourg

    Google Scholar 

  30. Rosen PP, Kosloff C, Lieberman PH et al (1978) Lobular carcinoma in situ of the breast. Detailed analysis of 99 patients with average follow-up of 24 years. Am J Surg Pathol 2:225–251

    Article  CAS  PubMed  Google Scholar 

  31. London SJ, Connoly JL, Schmitt SJ et al (1992) A prospective study of benign breast disease and the risk of breast cancer. JAMA 267:941–944

    Article  CAS  PubMed  Google Scholar 

  32. Hartmann LC, Sellers TA, Frost MH et al (2005) Benign breast disease and the risk of breast cancer. NEJM 353:229–237

    Article  CAS  PubMed  Google Scholar 

  33. Elsheikh TM, Silverman JF (2005) Follow up surgical excision is indicated when breast core needle biopsies show atypical lobular hyperplasia or lobular carcinoma in situ: a correlative study of 33 patients with review of the literature. Am J Surg Pathol 29:534–543

    Article  PubMed  Google Scholar 

  34. Mahoney MC, Robinson-Smith TM, Shaughnessy EA (2006) Lobular neoplasia at 11-gauge vacuum-assisted stereotactic biopsy: correlation with surgical excisional biopsy and mammographic follow-up. AJR 187:949–954

    Article  PubMed  Google Scholar 

  35. Brem RF, Lechner MC, Jackman RJ et al (2008) Lobular neoplasia at percutaneous breast biopsy: variables associated with carcinoma at surgical excision. AJR 190:637–641

    Article  PubMed  Google Scholar 

  36. Hwang H, Barke LD, Mendelson EB et al (2008) Atypical lobular hyperplasia and classic lobular carcinoma in situ in core biopsy specimens: routine excision is not necessary. Mod Pathol 21:1208–1216

    Article  PubMed  Google Scholar 

  37. Destounis SV, Murphy PF, Seifert PJ et al (2012) Management of patients diagnosed with lobular carcinoma in situ at needle core biopsy at a community-based outpatient facility. AJR 198:281–287

    Article  PubMed  Google Scholar 

Download references

Acknowledgments

The scientific guarantor of this publication is Enrico Cassano. The authors of this manuscript declare no relationships with any companies whose products or services may be related to the subject matter of the article. The authors state that this work has not received any funding. Patrick Maisonneuve kindly provided statistical advice for this manuscript. Institutional review board approval was obtained. Written informed consent was obtained from all subjects (patients) in this study. Methodology: retrospective, observational, performed at one institution.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Meroni Stefano.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Stefano, M., Carla, B.A., Giancarlo, P. et al. Underestimation rate of lobular intraepithelial neoplasia in vacuum-assisted breast biopsy. Eur Radiol 24, 1651–1658 (2014). https://doi.org/10.1007/s00330-014-3132-y

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00330-014-3132-y

Keywords

Navigation